North West Trauma Symposium 2017
University of Salford in collaboration with GM- CAT (Greater Manchester Academic Centre for Acute Tissue Injury and Trauma Care) and MAHSC (Manchester Academic Health Science Centre)
Major trauma accounts for 10% of fatalities worldwide with road traffic injuries alone ranked as the second highest cause of death among 15 to 29-year-olds. The North West Trauma Symposium proposes to facilitate the networking of regional Clinical, Academic and Industrial stakeholders with a view to improving trauma care and research in the North West.
The event hosted by the University of Salford in collaboration with GM-CAT will feature a spectrum of distinguished speakers, Research Poster sessions and unique networking opportunities. The symposium will also showcase preliminary findings from the ongoing Trauma Biomarker Project (UKCRN 19377), a multi-centre NIHR-Portfolio study led by the University of Salford in collaboration with the Central Manchester and Salford Royal Foundation Trusts. CPD accreditation from the Royal College of Anaesthesiologists has been applied for.
Please register interest below and we will keep you updated
|Prof Leela Biant||Academic Head of Dept. Trauma & Orthopaedic Surgery, University of Manchester, Consultant Trauma and Orthopaedic Surgeon, CMFT.|
|Prof Rick Body||Consultant in Emergency Medicine CMFT and NIHR Fellow.|
|Dr Tony Clayson||Consultant Orthopaedic Surgeon, Wrightington NHS Foundation Trust.|
|Prof Paul Dark||Chair of Critical Care Medicine, University of Manchester, NIHR National Specialty Lead for Critical Care & Trauma research.|
|Dr Jane Eddleston||Consultant in Intensive Care Medicine, Associate Medical Director, Clinical and Scientific Services CMFT.|
|Dr Antoinette Edwards||Executive Director TARN|
|Prof Tony Freemont||Professor of Pathology, Director of the Manchester Molecular Pathology Innovation Centre (the MRC/EPSRC Molecular Pathology node).|
|Dr James Hanison||Consultant Intensive Care, CMFT.|
|Dr Jim Langridge||Director Health Sciences, Waters Corporation, Manchester.|
|Prof Fiona Lecky||Consultant Emergency Medicine, SRFT, Research Director of the Trauma Audit and Research Network, University of Manchester.|
|Prof Kevin Mackway Jones||Consultant Emergency Physician, CMFT.|
|Dr Niroshini Nirmalan||Senior Lecturer, University of Salford, Manchester.|
|8:30-9:00||Registration and coffee|
Session 1: Chair: Dr. James Hanison (CMFT), Dr. Lucy Smyth (University of Salford)
Prof Fiona Lecky: Consultant Emergency Medicine, SRFT, Research Director of the Trauma Audit and Research Network, University of Manchester
Dr Antoinette Edwards: Executive Director Trauma Audit & Research Network (TARN)
TARN and trauma outcomes: Care processes and risk adjusted-survival
Prof Kevin Mackway Jones: Consultant Emergency Physician, CMFT
Evidence Synthesis in Trauma
Dr Tony Clayson: Consultant Orthopaedic Surgeon, Wrightington NHS Foundation Trust
Trauma services in the developing world
|10:35||Refreshment & Comfort Break|
Session 2: Chairs: Prof Marija Krstic-Demonacos (UoS) and Dr Daniel Horner (SRFT)
Prof Leela Biant: Academic Head of Dept. Trauma & Orthopaedic Surgery, University of Manchester, Consultant Trauma and Orthopaedic Surgeon, CMFT.
The unmet clinical and research needs of the trauma patient of 2020
Prof Rick Body: Consultant in Emergency Medicine CMFT and NIHR Fellow.
Developing a national portfolio of trauma research
Prof Paul Dark: Chair of Critical Care Medicine, University of Manchester, NIHR National Specialty Lead for Critical Care & Trauma research.
The future of Critical Care research in the UK
|12:30||Lunch & Networking|
SESSION 3 Chairs: Prof Mike Rogan (UoS), Dr. David Greensmith (UoS)
Dr Jane Eddleston: Consultant in Intensive Care Medicine, Associate Medical Director, Clinical and Scientific Services CMFT.
Reconfiguration of trauma services in the North West
Dr James Hanison: Consultant Intensive Care, CMFT.
Dr. Niroshini Nirmalan: Senior Lecturer, University of Salford.
Dr Lee Gethings: Senior Scientist, Waters Corporation, Manchester.
The Trauma Biomarker NIHR Portfolio study (UKCRN 19377): The story so far
Prof Tony Freemont: Professor of Pathology, Director of the Manchester Molecular Pathology Innovation Centre (the MRC/EPSRC Molecular Pathology node)
Biomarkers in medicine – bench to bedside; North West Strategy for commercialisation
Dr Jim Langridge: Director Health Sciences, Waters Corporation, Manchester.
Omics and clinical biomarker discovery
Panel Q and A
Closing Remarks from Chair
|16:05||Networking and Close|
|Date||Venue||Price from:||Status||Spaces||Book Now||Enquire|